Navigation Links
New Orthopedic Oncology Fellowship Program at Mount Clemens Brings Highly Trained Surgeons to State
Date:11/12/2008

Fellowship First In State To Train Surgeons For Rare But Often Mistreated

Cancer New Program Is Example Of Growth And Momentum At Mount Clemens Regional

Medical Center

MOUNT CLEMENS, Mich., Nov. 12 /PRNewswire/ -- The first fellowship program in the state for musculoskeletal tumors kicked off Oct. 1 at Mount Clemens Regional Medical Center under the stewardship of Ronald Irwin, M.D., an internationally known specialist in the diagnosis and treatment of bone cancers. Dr. Kenyatta Norman became the first orthopedic oncology fellow in Michigan last month. A second fellow is expected to be added to the program next year.

"The orthopedic oncology fellowship program is just one example of the investment and growth we're experiencing at Mount Clemens Regional Medical Center," said MCRMC President and CEO Mark O'Halla. "There are exciting things happening at Mount Clemens Regional and McLaren Health Care. Being able to attract top talent to create new programs that will benefit our patients and region are indicative of that."

Musculoskeletal tumors can occur in the muscles, nerves or the bones of the limbs. They can be primary tumors, or metastatic sites from other cancers. Because they are rare tumors, there are few experienced surgeons in orthopedic oncology that can accurately diagnose them, which sometimes leads to mistreatment of the tumors.

Irwin is one of the top-rated orthopedic oncologists in the country and one of only approximately 75 members worldwide of the Musculoskeletal Tumor Society. In addition to serving as Director of the Orthopedic Oncology at Mount Clemens Regional Medical Center, and Associate Director of McLaren Health Care's six Great Lakes Cancer Institute locations, Irwin teaches post- graduate physicians and orthopedic residents and medical students throughout the state. He has also co-authored a textbook chapter and published in some of the leading orthopedic medical journals. Irwin received his undergraduate and medical degrees at the University of Michigan, conducted his residency at the William Beaumont Hospital and fellowship at the Mayo Clinic, as well as limb salvage sabbatical at Harvard University.

Before joining Mount Clemens Regional, Irwin had served as the Executive Vice President and Chief Medical Officer of Beaumont Hospitals, as well as Corporate Director of Oncology Services and Director of the Musculoskeletal Tumor Services.

Norman completed her undergraduate and medical degree at Indiana University, and her orthopedic residency at Howard University. She is one of only 12 fellows training in orthopedic oncology in the nation.

"Including myself, there are only 12 surgeons training fellows in this specialty in the nation," Irwin said. "We see this as a wonderful opportunity to bring highly skilled surgeons to Southeast Michigan, and offer their talents to provide the best treatment available to our patients."


'/>"/>
SOURCE McLaren Health Care
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Orthopedic Development Corporations TruFUSE(R) Procedure Tops 1,750 Patients in First Year
2. Hanger Orthopedic Group, Inc. Announces Record Revenue of $162.3 Million and 20% Growth in Earnings Per Share for the Quarter Ended September 30, 2007
3. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cardio Devices, and the HealthShares(TM) Orthopedic Repair Indexes
4. QED International Announces Changes to the HealthShares(TM) Orthopedic Repair Index
5. Hanger Orthopedic Group, Inc. Announces Three Acquisitions Totaling Over $3.5 Million of Annual Net Revenue
6. Orthopedic Surgeon Contributes Knowledge on Research and Treatment in Weekly Blogs on MyOsteoarthritisCentral.com
7. Hanger Orthopedic Group, Inc. Announces 2007 Year-End Earnings Release Conference Call
8. Ascension Orthopedics Closes $21 Million Financing and Recruits an Orthopedics Industry Veteran as CEO
9. Ascension Orthopedics Launches the TITAN(TM) Humeral Resurfacing Device World Wide
10. Hanger Orthopedic Group, Inc. Announces Senior Leadership Succession Plan and Reaffirms Guidance
11. Hanger Orthopedic Group, Inc. Announces an 11% Sales Increase and a 35% Increase in EPS to $0.23 for the Quarter Ended December 31, 2007, Compared to $0.17 in the Prior Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... Linda, Ca (PRWEB) , ... February 27, 2017 ... ... Life Sciences, provides an overview on laser diffraction analysis as a tool to ... its capabilities, significance and potential to obtain improved results and novel scientific findings. ...
(Date:2/27/2017)... , ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. ... has disclosed that despite scientific studies, the Center for Disease Control ( CDC ) ... disease . Kenneth B. Liegner, M.D. has compiled into a single volume a ...
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine Coast ... in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the ... Mackenzie Alsager, showcases the Centre's commitment to innovation in drug rehab and alcohol ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair Institute, a ... an upgrade to the company's Yelp listing. Bay Area residents struggling from thinning ... as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as Follicular Unit ...
(Date:2/26/2017)... ... 25, 2017 , ... The February 13, 2017, assassination of Kim Jong-nam, the ... agents and the deadly use of chemical weapons. Many questions exist about the effect ... doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical Institute, and ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 2017 Mederi Therapeutics today announced the ... 2468 patients who received  Stretta Therapy  to treat ... Systematic Review and Meta-Analysis of Controlled and Prospective ... of Gastroesophageal Reflux Disease ", was published in ... , MD, head of the Esophageal and Swallowing ...
(Date:2/27/2017)... Feb. 27, 2017  International Biophysics Corporation, a global medical ... today announced a 34% revenue growth in 2016 when compared ... unit sales.  This growth was fueled by its AffloVest® sales ... to the expansion of its global sales of surgical product ... CEO, "As we enter our 25 th year in ...
(Date:2/27/2017)... 2017  Infinity Pharmaceuticals, Inc. (NASDAQ: INFI ... 37 th Annual Healthcare Conference on Monday, March ... Boston, MA. A live webcast of Infinity,s ... Infinity,s website at www.infi.com , and will be ... About Infinity,Infinity is an innovative biopharmaceutical company dedicated to ...
Breaking Medicine Technology: